New Rosacea Treatments

One of the hottest areas of interest online for rosacea sufferers is new rosacea treatments. From the industry heavyweights like Galderma, Allergan, Bayer, Valeant and Stiefel to little companies like MooGoo there is a lot of interest in the up and coming rosacea treatments. See below for the latest information about what is just over the horizon.

Recent Rosacea Blog Posts

Omiganan still in the rosacea pipeline

There aren’t many drugs currently in late development for rosacea. Finacea foam and Soolantra have been approved, and it looks like Azultro is on the way. One of the remaining drugs that is still inching its way through the approval process is Omiganan. Confirmation that Omiganan is still alive in the rosacea development pipeline comes from […]

Continue Reading

Rhofade is gentler than Mirvaso

Two small updates on the progress of topical oxymetazoline (now known as Rhofade) towards being available as another treatment for the redness of rosacea. The update tells us firstly that Allergan’s Oxymetazoline based product is in indeed in the final stages of approval, having completed Phase 3 trials and been submitted to the FDA for […]

Continue Reading

Gallo et al. patent Mast Cell Stabilizers

A 2014 patent application has surfaced that points to a potential new family of topical rosacea treatments. Drs. Gallo, Nardo and Muto have filed for a patent covering the role of mast cell stabilizers in treating rosacea. The patent also covers the inhibition and stimulation of vitamin D3, cathelicidin and serine protease, and how the […]

Continue Reading

New and Emerging Rosacea Topicals

One of the things I like to achieve with Rosacea News is to surface new and emerging rosacea topicals – giving a view of the sorts of topicals that are around the corner and might offer innovative treatments. One might sometimes feel that there isn’t much happening on behalf of us rosacea sufferers, but there […]

Continue Reading

3% Praziquantel (PZQ) for the redness of rosacea

This recent paper from International Journal of Dermatology introduces us to the compound known as Praziquantel. We learn that this active can be formulated into a 3% topical which shows antimicrobial activity. Praziquantel, also known as Biltricide, has been used orally for the treatment of parasitic worms. This trial is the first reported use of Praziquantel topcially. The study […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.